Defining Mechanisms of Surgical Site Infection After Oral Cancer Surgery

Description

The study design is an observational cohort study of patients undergoing standard of care oral cavity reconstruction. An observational study is required to prospectively evaluate microbial and antibiotic mechanisms underlying surgical site infection after oral cavity reconstruction.

Conditions

Oral Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

The study design is an observational cohort study of patients undergoing standard of care oral cavity reconstruction. An observational study is required to prospectively evaluate microbial and antibiotic mechanisms underlying surgical site infection after oral cavity reconstruction.

Defining Mechanisms of Surgical Site Infection After Oral Cancer Surgery

Defining Mechanisms of Surgical Site Infection After Oral Cancer Surgery

Condition
Oral Cancer
Intervention / Treatment

-

Contacts and Locations

Milwaukee

Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States, 53226

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Provide signed and dated informed consent form. Subjects must have the capacity to consent for themselves.
  • 2. Willing to comply with all study procedures and be available for the duration of the study.
  • 3. Aged 21 years or older.
  • 4. Planned to undergo standard of care oral cavity reconstruction surgery with use of ampicillin/sulbactam as the prophylactic antibiotic agent administered.
  • 5. Oral cavity reconstruction surgery will be defined as any surgical procedure which includes a planned connection from the oral cavity to the neck soft tissues which is repaired with a free or regional tissue flap.
  • 6. History of oral or oropharyngeal cancer.
  • 1. Allergy to ampicillin/sulbactam.
  • 2. Vulnerable populations including pregnant women and prisoners.

Ages Eligible for Study

21 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Medical College of Wisconsin,

Joseph Zenga, MD, PRINCIPAL_INVESTIGATOR, Medical College of Wisconsin

Study Record Dates

2027-05-01